Progress in the treatment of rheumatoid arthritis

JAMA

Volumn 286, Issue 22, 2001, Pages 2787-2790

  Pisetsky, David S ^a,b   St Clair, E William ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOMALATE; AZATHIOPRINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE;

AUTOIMMUNE DISEASE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CORTICOSTEROID THERAPY; DEMYELINATING DISEASE; FATIGUE; GASTROINTESTINAL TOXICITY; HUMAN; HYPERSENSITIVITY; HYPERTENSION; INFECTION; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEINURIA; RASH; REVIEW; RHEUMATOID ARTHRITIS; STOMATITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0035852136     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.22.2787     Document Type: Review

References (27)

1. Epidemiology of rheumatoid arthritis
2. A reappraisal of HAQ disability in rheumatoid arthritis
3. Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scores
4. Invasive fibroblast-like synoviocytes in rheumatoid arthritis
5. The coxibs, selective inhibitors of cyclooxygenase
6. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial
7. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
8. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs
9. The effect of glucocorticoids on joint destruction in rheumatoid arthritis
10. The effectiveness of early treatment with "second-line" antirheumatic drugs
11. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
12. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate
13. Methotrexate use in rheumatoid arthritis
14. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis
15. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis
16. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis
17. Etanercept therapy in rheumatoid arthritis
18. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
19. Infliximab and methotrexate in the treatment of rheumatoid arthritis
20. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis
21. The combination of leflunomide and methotrexate in patients with active rheumatoid arthritis who are failing on MTX treatment alone
22. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
23. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
24. Comparison of combination therapy with singledrug therapy in early rheumatoid arthritis
25. Combination therapy in early rheumatoid arthritis
26. Treatment of poor-prognosis early rheumatoid arthritis
27. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications